EV-302: The Trial That Revolutionized First-Line Bladder Cancer Treatment
EV-302: The Trial That Revolutionized First-Line Bladder Cancer Treatment Article Title: Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer Authors: Thomas Powles, Begona P. Valderrama, Shilpa Gupta, Jens Bedke, Eiji Kikuchi, Jennifer Hoffman-Censits, Gopa Iyer, Christof Vulsteke, Se Hoon Park, Sang Joon Shin, and the EV-302/KEYNOTE-A39 Study Group Journal: New England Journal of…